VivoSim Labs (VIVS) EBIT Margin (2011 - 2026)
VivoSim Labs (VIVS) posted EBIT Margin of 15327.78% for Q2 2026, down 92.38% on a QoQ basis from 7967.5% in Q1 2026, and down 744940.0% year-over-year from N/an in Q2 2025.
Powered by 
Analysis
VivoSim Labs (VIVS) EBIT Margin (2011 - 2026) Analysis & Trends
VivoSim Labs has reported EBIT Margin for 14 years, with the latest figure at 15327.78% in Q2 2026.
- On a quarterly basis, EBIT Margin fell 744940.0% year-over-year to 15327.78% in Q2 2026; TTM through Jun 2026 was 10116.96%, a 156415.0% decrease from a year earlier, with the FY2026 full-year figure at 8768.7%, down 759.0% from the prior year.
- EBIT Margin was 15327.78% for Q2 2026 at VivoSim Labs, down from 7967.5% in the prior quarter.
- The five-year high for EBIT Margin was 127.53% in Q1 2022, with the low at 73600.0% in Q4 2023.
- Average EBIT Margin over 5 years is 11930.6%, with a median of 8324.78% recorded in 2024.
- The sharpest annual moves came in 2023 and 2024: EBIT Margin plunged 7103588 bps in 2023, then jumped 5915000 bps in 2024.
- Over 5 years, EBIT Margin stood at 2564.12% in 2022, then sank by 2770 bps to 73600.0% in 2023, then soared by 80 bps to 14450.0% in 2024, then grew by 27 bps to 10576.92% in 2025, then tumbled by 45 bps to 15327.78% in 2026.
- The last three EBIT Margin figures came in at 15327.78% (Q2 2026), 7967.5% (Q1 2026), and 10576.92% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 11.58% |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 20.76% |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 6.68% |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 11.94% |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 2.18% |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -290.47% |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -2.69% |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -218,381.69% |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -15,327.78% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -15,327.78% |
| Mar 31, 2026 | -7,967.50% |
| Dec 31, 2025 | -10,576.92% |
| Sep 30, 2025 | -9,410.71% |
| Jun 30, 2025 | -7,878.38% |
| Mar 31, 2025 | -6,184.31% |
| Dec 31, 2024 | -14,450.00% |
| Sep 30, 2024 | -8,693.33% |
| Jun 30, 2024 | -8,682.05% |
| Mar 31, 2024 | -10,675.86% |
| Dec 31, 2023 | -73,600.00% |
| Jun 30, 2023 | -5,593.33% |
| Mar 31, 2023 | -4,801.85% |
| Dec 31, 2022 | -2,564.12% |
| Sep 30, 2022 | -4,355.84% |
| Mar 31, 2022 | -127.53% |
| Dec 31, 2019 | -1,756.38% |
| Sep 30, 2019 | -555.04% |
| Jun 30, 2019 | -976.20% |
| Mar 31, 2019 | -1,053.24% |